Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts
06:50pm, Thursday, 22'nd Jan 2026
Viking Therapeutics, Inc. (VKTX) closed at $34.09 in the latest trading session, marking a +2.13% move from the prior day.
Tema Heart & Health ETF Buys 5,473 Shares of Viking Therapeutics Inc (VKTX)
09:10pm, Wednesday, 21'st Jan 2026
Summary Tema Heart and Health ETF raised its stake in Viking Therapeutics Inc (VKTX) by 146.02%, purchasing 5,473 shares to own 9,221 shares valued at ab
2 Bargain Stocks You Can Buy for Less Than $100 Right Now
03:21pm, Wednesday, 21'st Jan 2026
Viking Therapeutics doesn't have any approved products in its portfolio, but VK2735 has shown encouraging weight loss results in clinical trials. PayPal's growth has been poor in recent quarters, but
1 Stock That Could Soar by 175%, According to Wall Street
10:30am, Wednesday, 21'st Jan 2026
Viking Therapeutics' price target implies a juicy upside from its current levels. The stock's most important catalysts will likely have to wait until next year.
Inspire Advisors LLC Buys Shares of 22,615 Viking Therapeutics, Inc. $VKTX
04:45am, Wednesday, 21'st Jan 2026
Inspire Advisors LLC purchased a new position in shares of Viking Therapeutics, Inc. (NASDAQ: VKTX) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchan
What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026?
03:05pm, Tuesday, 20'th Jan 2026
Viking Therapeutics' stock was volatile in 2025 due to clinical trial results. VK2735's oral form faced safety concerns but remains promising.
3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026
08:29am, Tuesday, 20'th Jan 2026
The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries higher-than-average risk.
Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know
06:45pm, Thursday, 15'th Jan 2026
Viking Therapeutics, Inc. (VKTX) reached $31.86 at the closing of the latest trading day, reflecting a -7.21% change compared to its last close.
Viking Therapeutics, Inc. (VKTX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
01:35am, Tuesday, 13'th Jan 2026
Viking Therapeutics, Inc. (VKTX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Appetite for weight-loss deals broader than visible, Viking CEO says
07:19pm, Monday, 12'th Jan 2026
Weight-loss drug developer Viking Therapeutics CEO said on Monday that strategic interest in weight-loss drug deals is broader than it appears, as drugmakers seek to tap into the potential $150 billio
Publication Highlights Impressive Weight Loss of Up to 14.7% from Baseline After 13 Weeks of Treatment; No Plateau Observed VK2735 Currently Being Evaluated in VANQUISH Phase 3 Registrational Program
What Investors Should Know About a Viking Therapeutics Insider's $2 Million Stock Sale
06:17am, Sunday, 11'th Jan 2026
One Viking Therapeutics insider sold 57,661 shares of the company for about $1.9 million on Monday. The sale represented 23.29% of Zante's direct holdings, which fell from 247,552 to 189,891 shares, a
Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know
06:47pm, Friday, 09'th Jan 2026
Viking Therapeutics, Inc. (VKTX) reached $31.99 at the closing of the latest trading day, reflecting a +1.07% change compared to its last close.
VKTX Completes Enrollment in Phase I Maintenance Study of Obesity Drug
11:01am, Friday, 09'th Jan 2026
Viking Therapeutics completes enrollment in a phase I maintenance study of VK2735, testing flexible oral and injectable dosing after initial weight loss in obese adults.
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet
10:31am, Thursday, 08'th Jan 2026
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
